MS Society of Canada Opens 45th Read-a-Thon Fundraiser on Jan. 27
The MS Society of Canada is hosting its annual MS Read-a-Thon, a fundraiser that supports vital services to…
Articles by Yedida Y Bogachkov PhD
Trial of Cannabidiol-derived EHP-101 for Relapsing MS Enrolling Soon
Emerald Health Pharmaceuticals will soon begin enrollment in a Phase 2a clinical trial investigating its cannabidiol-derived therapy EHP-101 in…
MS Patients at Greater Cancer Risk for Reasons That Include Lifestyle
People with multiple sclerosis (MS) are at greater risk of developing cancer than the general population, according to a…
Cognitive Dysfunction Found to Increase Risk of Death in MS
Cognitive dysfunction in patients with multiple sclerosis (MS) is predictive of worse outcomes, including clinical progression of the disease…
Phase 1 Trial of ANK-700 for RRMS Advancing to Multiple Doses
A Phase 1 clinical trial investigating the safety and tolerability of Anokion‘s ANK-700 in people with relapsing-remitting multiple sclerosis (RRMS)…
Study Finds Lemtrada Safe for MS Patients With Other Autoimmunity
Other autoimmune conditions, particularly those characterized by the presence of anti-TPO antibodies, should not preclude patients with multiple sclerosis…
NHS England and Wales to Offer Ponvory at Low or No Cost for RRMS
Note: This story was updated Jan. 12, 2022, to note that Ponvory is approved in the U.K. for people…
Management Programs May Help Keep Fatigue Stable Over Long-term
Fatigue management — whether through a symptom-specific self-management program or through general education regarding managing multiple sclerosis (MS) —…
Pets Raise Sense of Well-being in Pandemic, But Challenges Remain
Owning a dog, cat or other household pet during the ongoing COVID-19 pandemic has helped multiple sclerosis (MS) patients…
Patients Feel Emotions Intensely But Can Struggle to See Them in Others
People with multiple sclerosis (MS) have more difficulty recognizing emotions in others, and they experience emotions more intensely than…
Neurostimulation via Neubie Aids Movement With MS, Company Says
Neubie, a neuromuscular electrical stimulation device developed by NeuFit, led to measurable improvements in function and strength in the…
‘Giving Tuesday’ Donations to MS Society of Canada Being Matched
Donations to the Multiple Sclerosis Society of Canada will double in value for this year’s Giving Tuesday on Nov.
First Patient Dosed in Phase 1 Trial of IMS001 Therapy
ImStem Biotechnology announced that the first patient in its Phase 1 clinical trial for IMS001, an investigational treatment for…
Autoimmune Patients Want Clearer COVID-19 Vaccine Info
Patients with autoimmune diseases, including multiple sclerosis (MS), are uncertain about how to protect themselves against COVID-19, especially with…
Cladribine as Injection May Limit Relapsing MS Progression for Years
Patients with relapsing multiple sclerosis (MS) treated with subcutaneous cladribine saw limited disease progression over a follow-up period of…
FDA Approves Reintroduced Cortrophin Gel for MS Exacerbations
The injectable ACTH gel medication Cortrophin Gel (repository corticotropin injection), first introduced in the U.S. in the 1950s, will…
Brain Atrophy, Serum NfL Levels May Predict Cognition Early in MS
A blood test for serum neurofilament light chain (sNfL) levels, along with radiological findings, can help to detect early cognitive…
13th Annual Burgers to Beat MS Day Raises $1.4M
Though 13 may be an unlucky number for some, that was not the case for the 13th Annual A&W Canada…